No registrations found.
ID
Source
Brief title
Health condition
Dementia, Alzheimer's Disease, young-onset
Sponsors and support
Intervention
Outcome measures
Primary outcome
The clinical value of [18F]Flutemetamol PET.
Secondary outcome
Prognostic value of [18F]Flutemetamol PET.
Background summary
In this study we aim to establish the clinical value of [18F]Flutemetamol PET imaging in patients with young onset dementia, in which a firm and accurate diagnosis constitutes an important first step in future management.
Study objective
18F]Flutemetamol PET will have additional clinical value in diagnosis of patients with young onset dementia.
Study design
Baseline, 1 and 2 year follow-up.
Intervention
[18F]Flutemetamol injection.
Alzheimer Center<br>
De Boelelaan 1118<br>
PO Box 7057
M.D. Zwan
Amsterdam 1007 MB
The Netherlands
m.zwan@vumc.nl
Alzheimer Center<br>
De Boelelaan 1118<br>
PO Box 7057
M.D. Zwan
Amsterdam 1007 MB
The Netherlands
m.zwan@vumc.nl
Inclusion criteria
Young (age of diagnosis < 70 years) patients with (suspicion of) dementia.
Exclusion criteria
1. Have ever participated in an experimental study with an amyloid targeting agent;
2. Females of childbearing potential who are not surgically sterile, not refraining from sexual activity or not using reliable methods of contraception.
Design
Recruitment
Followed up by the following (possibly more current) registration
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL3592 |
| NTR-old | NTR3743 |
| CCMO | NL39995.029.12 |
| ISRCTN | ISRCTN wordt niet meer aangevraagd. |
| OMON | NL-OMON39989 |